Experienced drug development leader with expertise in advancing cell and gene therapies, biologics, and vaccines from preclinical to late phase clinical stages: successfully led five diverse programs using a cross-functional matrix team approach. I specialized in ophthalmology, infectious diseases, and orthopedics, with a strong track record in regulatory compliance, CDMO collaboration, vendor management and CMC manufacturing oversight. Recognized for scientific leadership through global presentations, workshops, and contributions to innovative therapies addressing unmet medical needs.